Founders Fund V Management 13F annual report
Founders Fund V Management is an investment fund managing more than $1.16 billion ran by Neil Pai. There are currently 3 companies in Mr. Pai’s portfolio. The largest investments include Applied Molecular Trans Inc and Unity Biotechnology Inc, together worth $1.06 billion.
$1.16 billion Assets Under Management (AUM)
As of 7th August 2023, Founders Fund V Management’s top holding is 3,611,615 shares of Applied Molecular Trans Inc currently worth over $932 million and making up 80.2% of the portfolio value.
In addition, the fund holds 49,172 shares of Unity Biotechnology Inc worth $125 million, whose value fell 33.5% in the past six months.
The third-largest holding is Rigetti Computing Inc worth $104 million.
Currently, Founders Fund V Management's portfolio is worth at least $1.16 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Founders Fund V Management
The Founders Fund V Management office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, Neil Pai serves as the General Counsel at Founders Fund V Management.
Recent trades
In the most recent 13F filing, Founders Fund V Management revealed that it had opened a new position in
Unity Biotechnology Inc and bought 49,172 shares worth $125 million.
On the other hand, there are companies that Founders Fund V Management is getting rid of from its portfolio.
Founders Fund V Management closed its position in Leafly Holdings Inc on 14th August 2023.
It sold the previously owned 354,339 shares for $1.59 million.
One of the smallest hedge funds
The two most similar investment funds to Founders Fund V Management are Doyle Wealth Management and Neville Rodie & Shaw Inc. They manage $1.16 billion and $1.16 billion respectively.
Neil Pai investment strategy
Founders Fund V Management’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 10.8% of
the total portfolio value.
The fund focuses on investments in the United States as
33.3% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
33% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $39.6 million.
The complete list of Founders Fund V Management trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
Security | Shares Owned | Value | Allocation |
---|---|---|---|
Applied Molecular Trans Inc |
No change
3,611,615
|
$931,797,000 | 80.24% |
Unity Biotechnology Inc |
Opened
49,172
|
$125,389,000 | 10.80% |
Rigetti Computing Inc |
Opened
88,621
|
$104,130,000 | 8.97% |
Leafly Holdings Inc |
Closed
354,339
|
$1,594,000 | |
Unity Biotechnology Inc |
Closed
491,751
|
$275,000 | |
No transactions found | |||
Showing first 500 out of 5 holdings |
Hedge funds similar to Founders Fund V Management
- Ymca Retirement Fund
- James Morgan Rutman
- Van Hulzen Asset Management
- Devon
- Rbc Capital Markets Arbitrage
- Lee Danner & Bass Inc
- Neville Rodie & Shaw Inc
- Doyle Wealth Management
- Sva Wealth Management
- Praesidium Investment Management
- Mivtachim The Workers Social Insurance Fund (under Special Management)
- Gillson Capital L.P.
- Alua Capital Management L.P.
- Kimelman & Baird